Recursion Pharmaceuticals Earnings Yield

Earnings Yield of Recursion Pharmaceuticals is -35.50 % in 2026.

Earnings Yield of Recursion Pharmaceuticals changed from -25.53 % to -35.50 %, representing a 39.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield Recursion Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's Recursion Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.